Clinical significance of Golgi protein 73 in liver cirrhosis and its relationship with radiological parameters
LI Jiana1,2, WANG Dongxu1, HU Yulin2, ZHU Hongbin1
1. The 983rd Hospital of Chinese PLA Joint Logistics Support Force, Tianjin 300142 China; 2. The First Hospital of Jilin University, Changchun 130021 China
李佳娜, 王东旭, 胡玉琳, 朱宏斌. 高尔基体蛋白73在肝硬化中表达水平的临床意义及与影像学指标的关系[J]. 中国辐射卫生, 2022, 31(4): 512-516.
LI Jiana, WANG Dongxu, HU Yulin, ZHU Hongbin. Clinical significance of Golgi protein 73 in liver cirrhosis and its relationship with radiological parameters. Chinese Journal of Radiological Health, 2022, 31(4): 512-516.
[1] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world[J]. J Hepatol, 2019, 70(1): 151-171. DOI: 10.1016/j.jhep.2018.09.014 [2] Xia YY, Zhang YY, Shen MJ, et al. Golgi protein 73 and its diagnostic value in liver diseases[J]. Cell Prolif, 2019, 52(2): e12538. DOI: 10.1111/cpr.12538 [3] Gatselis NK, Tornai T, Shums Z, et al. Golgi protein-73: a biomarker for assessing cirrhosis and prognosis of liver disease patients[J]. World J Gastroenterol, 2020, 26(34): 5130-5145. DOI: 10.3748/wjg.v26.i34.5130 [4] Yao MJ, Wang LJ, Leung PSC, et al. The clinical significance of GP73 in immunologically mediated chronic liver diseases: experimental data and literature review[J]. Clin Rev Allergy Immunol, 2018, 54(2): 282-294. DOI: 10.1007/s12016-017-8655-y [5] 中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志,2019,27(11):846-865. DOI: 10.3760/cma.j.issn.1007-3418.2019.11.008 Chinese Society of Hepatology, Chinese Medical. Chinese guidelines on the management of liver cirrhosis[J]. Chin J Hepatol, 2019, 27(11): 846-865. DOI: 10.3760/cma.j.issn.1007-3418.2019.11.008 [6] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华肝脏病杂志,2019,27(12):938-961. DOI: 10.3760/cma.j.issn.1007-3418.2019.12.007 Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Society of Hepatology, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version)[J]. Chin J Hepatol, 2019, 27(12): 938-961. DOI: 10.3760/cma.j.issn.1007-3418.2019.12.007 [7] 中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版)[J]. 中华传染病杂志,2020,38(1):9-28. DOI: 10.3760/cma.j.issn.1000-6680.2020.01.004 Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline of prevention and treatment for hepatitis C (2019 version)[J]. Chin J Infect Dis, 2020, 38(1): 9-28. DOI: 10.3760/cma.j.issn.1000-6680.2020.01.004 [8] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015)[J]. 肝脏,2015,20(12):969-982. DOI: 10.14000/j.cnki.issn.1008-1704.2015.12.005 Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Gastroenterology, Chinese Medical Association, Chinese Society of Infectious Diseases. Consensus on the diagnosis and management of autoimmune hepatitis (2015)[J]. Chin Hepatol, 2015, 20(12): 969-982. DOI: 10.14000/j.cnki.issn.1008-1704.2015.12.005 [9] 刘悦, 康澍, 赵天佐, 等. 肝硬化结节和小肝癌的影像学研究[J]. 中国辐射卫生,2019,28(2):218-222. DOI: 10.13491/j.issn.1004-714X.2019.02.028 Liu Y, Kang S, Zhao TZ, et al. Imaging study of cirrhotic nodules and small hepatocellular carcinoma[J]. Chin J Radiol Health, 2019, 28(2): 218-222. DOI: 10.13491/j.issn.1004-714X.2019.02.028 [10] Dong M, Chen ZH, Li X, et al. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma[J]. Oncol Lett, 2017, 14(5): 6277-6284. DOI: 10.3892/ol.2017.6938 [11] Yao HJ, Wang YL. Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension[J]. Open Life Sci, 2020, 15(1): 981-987. DOI: 10.1515/biol-2020-0101
